World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
81
Citations
35721
World Ranking
3799
National Ranking
1881

Research.com Recognitions

  • 2016 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Robert A. Copeland is affiliated with Accent Therapeutics in the United States. Their research spans multiple fields including Medicine and Environmental Science, with a focus on subfields such as Pulmonary and Respiratory Medicine, Health, Toxicology and Mutagenesis, and Cardiology and Cardiovascular Medicine.

The scientist's work addresses several main topics covering Infection Control and Ventilation, Climate Change and Health Impacts, and Cardiovascular Effects of Exercise.

Robert A. Copeland has contributed to the following recent publication:

  • End-to-end SARS-CoV-2 transmission risks in sport: Current evidence and practical recommendations, 2021, South African Journal of Sports Medicine

Frequent co-authors collaborating with Robert A. Copeland include:

  • Ben Jones
  • Gemma Phillips
  • Federica Valeriani
  • Thomas Edwards
  • Emily R. Adams

Their contributions have appeared primarily in the South African Journal of Sports Medicine.

Robert A. Copeland was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2016.

Best Publications

  • IDENTIFICATION OF A NOVEL INHIBITOR OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE

    Margaret F. Favata;Kurumi Y. Horiuchi;Elizabeth J. Manos;Andrea J. Daulerio

  • Enzymes : a practical introduction to structure, mechanism, and data analysis

    Robert Allen Copeland

  • Drug–target residence time and its implications for lead optimization

    Robert A. Copeland;David L. Pompliano;Thomas D. Meek

  • Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists

    Robert Allen Copeland

  • Evaluation of enzyme inhibitors in drug discovery

    Robert Allen Copeland

  • Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor

    Scott R. Daigle;Edward J. Olhava;Carly A. Therkelsen;Christina R. Majer

  • The promise and peril of chemical probes.

    Cheryl H. Arrowsmith;James E. Audia;Christopher Austin;Jonathan Baell

  • A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells

    Sarah K Knutson;Tim J Wigle;Natalie M Warholic;Christopher J Sneeringer

  • Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins.

    M. D. Tortorella;T. C. Burn;M. A. Pratta;I. Abbaszade

  • Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2

    Sarah K. Knutson;Natalie M. Warholic;Tim J. Wigle;Christine R. Klaus

  • Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

    Christopher J. Sneeringer;Margaret Porter Scott;Kevin W. Kuntz;Sarah K. Knutson

  • Potent inhibition of DOT1L as treatment of MLL-fusion leukemia.

    Scott R. Daigle;Edward J. Olhava;Carly A. Therkelsen;Aravind Basavapathruni

  • The drug-target residence time model: a 10-year retrospective

    Robert A. Copeland

  • Residence time of receptor-ligand complexes and its effect on biological function.

    Peter J. Tummino;Robert A. Copeland

  • Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family.

    Ilgar Abbaszade;Rui-Qin Liu;Fude Yang;Stuart A. Rosenfeld

  • Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma

    Sarah K. Knutson;Satoshi Kawano;Yukinori Minoshima;Natalie M. Warholic

  • Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study

    Antoine Italiano;Jean-Charles Soria;Maud Toulmonde;Jean-Marie Michot

  • Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

    Robert A. Copeland;Jean M. Williams;John Giannaras;Sherrill Nurnberg

  • MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.

    John V. Duncia;Joseph B. Santella;C.Anne Higley;William J. Pitts

  • A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models

    Elayne Chan-Penebre;Kristy G Kuplast;Christina R Majer;P Ann Boriack-Sjodin

Frequent Co-Authors

J. Joshua Smith
J. Joshua Smith Memorial Sloan Kettering Cancer Center
James M. Trzaskos
James M. Trzaskos Bristol-Myers Squibb (Germany)
Thomas G. Spiro
Thomas G. Spiro University of Washington
William F. DeGrado
William F. DeGrado University of California, San Francisco
Giulio Superti-Furga
Giulio Superti-Furga Medical University of Vienna
Stefan Knapp
Stefan Knapp Goethe University Frankfurt
Scott A. Armstrong
Scott A. Armstrong Harvard University
Matthieu Schapira
Matthieu Schapira University of Toronto
Cheryl H. Arrowsmith
Cheryl H. Arrowsmith Structural Genomics Consortium

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Biology or Biochemistry, a range of online degrees can expand your career opportunities in healthcare, research, and management. Many students transition from these fields into healthcare leadership by enrolling in top cahme-accredited mha programs. These programs focus on high-level skills needed to manage hospitals, labs, and health organizations.

For those interested in advanced nursing roles, the msn to dnp online no clinicals pathway is an option. These flexible online programs allow qualified nurses to earn their DNP without in-person clinicals, making it easier to balance work and study.

If you’re aiming for academic or executive roles, consider a phd in healthcare management. This degree prepares you to lead research projects, direct policy, or teach at the university level.

Finally, students fascinated by drug development or pharmacy can explore the best online pharmacy school options. A doctorate in pharmacy opens doors to clinical, research, and industry leadership roles.

Best Scientists Citing Robert A. Copeland

Trending Scientists